Lenoss Medical’s Mission: Placing natural bone where new bone is needed most
With a philosophy that ingenuity lies in simplicity, Lenoss is pioneering the first biological implant, intended to directly stabilize the damaged vertebrae while delivering osteoinductive and osteoconductive technology for the development of new bone and long-term healing of the spine.
Fellow Spotlight: Lenoss Medical
Lenoss Medical has entered the scene to introduce a disruptive new method of vertebral body augmentation. Lenoss Medical is a start-up with an innovative, biological bone implant technology for the treatment of painful spinal fractures. When natural, biological bone implants are used in weak, fractured vertebrae, a regenerative process can occur: new bone building, and repair of the fractured vertebrae may occur.
Press Release: Rhode Island based startup, Lenoss Medical raises $1.3 million to launch new spinal technology challenging the osseous healing paradigm
Providence, RI – May 5th, 2021 – Lenoss Medical, a biomedical start up focused on physiological repair of osteoporotic spinal fractures has raised $1.3 million in a seed funding round from Cherrystone Angel Group, Slater Technology Fund, Walnut Ventures, Beacon Angels, River Valley Investors, Magpie Neurosurgical Innovation Fund and Mr. Hansjoerg Wyss.
What a Med Tech Entrepreneur Wished They'd Known with Dom Messerli.
“In hindsight, everything is 20-20”, says Dom Messerli, an engineer turned entrepreneur who has been spending the last 3 years developing an entirely natural treatment for osteoporotic vertebral compression fractures at his company, Lenoss Medical. As part of our research for the NEMIC Med Tech Leadership Program, we interviewed a number of professionals within the Med Tech development space, from investors and scientists to entrepreneurs. Messerli's background encompasses a number of key skill-sets required to develop and commercialize a Med Tech product.